Newspaper Publication of Standalone Financial Results for the quarter and half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics Ltd has submitted to BSE copies of a newspaper advertisement dated November 13, 2025, containing the extract of its unaudited standalone financial results for the second quarter and half year ended September 30, 2025. The advertisement was published in Business Standard (English, all editions) and Parshuram Samachar (Marathi, Mumbai edition), as mandated by SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulation 47. The same publication is also available on the company's website. This is a routine compliance intimation signed by the Company Secretary, and the actual financial figures are not reproduced in this filing.
This is a standard regulatory compliance disclosure with no direct impact on stock price or shareholders. Investors should look at the separate detailed financial results filing or the newspaper advertisement itself for the actual Q2 numbers, revenue, and profit figures.